Literature DB >> 24853882

Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves' disease.

Roberto Vita1, Daniela Lapa, Francesco Trimarchi, Salvatore Benvenga.   

Abstract

The aim of this study was to evaluate the relationship of stressful events (SE) with the onset and outcome of Graves' disease (GD). Over a period of 21 years, we enrolled 58 consecutive patients in whom at least one SE had occurred ≤12 months before the onset of GD. Patients were treated with antithyroid drugs (ATD) for ≥12 months and followed up for ≥5 years after ATD withdrawal. We divided patients in three groups: REM (who reached remission; 25.9%); EXA (who experienced ≥1 exacerbation during ATD; 10.3%); and REL (who experienced ≥1 relapse after ATD withdrawal; 63.8%). The average age at onset was similar in the three groups. All males aged ≤25 years at GD onset relapsed at least once; no patient aged ≥51 years at GD onset relapsed ≥2 times. All patients who exacerbated or relapsed had at least one SE preceding each exacerbation or relapse. The time lag between SE and onset of GD (19.3±11.9 weeks) correlated with the age at onset (r=0.292, P=0.0002), particularly in the REL group (r=0.346, P=0.001). Overall, EXA and REL patients experienced more SE than REM patients (P=0.0002 and P=0.003, respectively). In the REL group, the overall number of SE was correlated with the number of relapses (r=0.486, P<0.0001). There exist GD patients who are prone to develop hyperthyroidism and its recurrences when exposed to SE. They are relatively young; the younger these patients are, the shorter is the time lag between SE and the onset of hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24853882     DOI: 10.1007/s12020-014-0289-8

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  40 in total

1.  Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment.

Authors:  P Vitti; T Rago; L Chiovato; S Pallini; F Santini; E Fiore; R Rocchi; E Martino; A Pinchera
Journal:  Thyroid       Date:  1997-06       Impact factor: 6.568

2.  Stressful life events and Graves' disease.

Authors:  B Winsa; H O Adami; R Bergström; A Gamstedt; P A Dahlberg; U Adamson; R Jansson; A Karlsson
Journal:  Lancet       Date:  1991-12-14       Impact factor: 79.321

3.  [Triggering role of emotional stress and childbirth. Unexpected occurrence of Graves' disease compared to 96 cases of Hashimoto thyroiditis and 97 cases of thyroid nodules].

Authors:  R C Martin-du Pan
Journal:  Ann Endocrinol (Paris)       Date:  1998-07       Impact factor: 2.478

4.  Stressful life events and smoking were associated with Graves' disease in women, but not in men.

Authors:  K Yoshiuchi; H Kumano; S Nomura; H Yoshimura; K Ito; Y Kanaji; Y Ohashi; T Kuboki; H Suematsu
Journal:  Psychosom Med       Date:  1998 Mar-Apr       Impact factor: 4.312

5.  Precipitating factors in hyperthyroidism.

Authors:  M E Forteza
Journal:  Geriatrics       Date:  1973-02

Review 6.  The role of stress in the clinical expression of thyroid autoimmunity.

Authors:  Agathocles Tsatsoulis
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

7.  The significant increase in incidence of Graves' disease in eastern Serbia during the civil war in the former Yugoslavia (1992 to 1995).

Authors:  N Paunkovic; J Paunkovic; O Pavlovic; Z Paunovic
Journal:  Thyroid       Date:  1998-01       Impact factor: 6.568

8.  Age and gender predict the outcome of treatment for Graves' hyperthyroidism.

Authors:  A Allahabadia; J Daykin; R L Holder; M C Sheppard; S C Gough; J A Franklyn
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

9.  Life events in the pathogenesis of Graves' disease. A controlled study.

Authors:  N Sonino; M E Girelli; M Boscaro; F Fallo; B Busnardo; G A Fava
Journal:  Acta Endocrinol (Copenh)       Date:  1993-04

10.  Age and stress as determinants of the severity of hyperthyroidism caused by Graves' disease in newly diagnosed patients.

Authors:  Xander G Vos; Natalie Smit; Erik Endert; Jos F Brosschot; Jan G P Tijssen; Wilmar M Wiersinga
Journal:  Eur J Endocrinol       Date:  2008-10-30       Impact factor: 6.664

View more
  19 in total

Review 1.  Relapse prediction in Graves´ disease: Towards mathematical modeling of clinical, immune and genetic markers.

Authors:  Christoph Langenstein; Diana Schork; Klaus Badenhoop; Eva Herrmann
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

Review 2.  Molecular mimicry and autoimmune thyroid disease.

Authors:  Salvatore Benvenga; Fabrizio Guarneri
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

3.  Certain HLA alleles are associated with stress-triggered Graves' disease and influence its course.

Authors:  Roberto Vita; Daniela Lapa; Francesco Trimarchi; Giuseppe Vita; Poupak Fallahi; Alessandro Antonelli; Salvatore Benvenga
Journal:  Endocrine       Date:  2016-03-07       Impact factor: 3.633

4.  Are Perinatal Events Risk Factors for Childhood Thyroid Autoimmunity?

Authors:  Berglind Jonsdottir; Markus Lundgren; Sara Wallengren; Åke Lernmark; Ida Jönsson; Helena Elding Larsson
Journal:  Eur Thyroid J       Date:  2017-09-19

5.  Microbiome and Graves' Orbitopathy.

Authors:  Giulia Masetti; Marian Ludgate
Journal:  Eur Thyroid J       Date:  2020-11-05

Review 6.  Thyroid Allostasis-Adaptive Responses of Thyrotropic Feedback Control to Conditions of Strain, Stress, and Developmental Programming.

Authors:  Apostolos Chatzitomaris; Rudolf Hoermann; John E Midgley; Steffen Hering; Aline Urban; Barbara Dietrich; Assjana Abood; Harald H Klein; Johannes W Dietrich
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-20       Impact factor: 5.555

Review 7.  Thyroid Autoimmunity and Antiphospholipid Syndrome: Not Such a Trivial Association.

Authors:  Mathilde Versini
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-21       Impact factor: 5.555

Review 8.  Thyroid-Stimulating Hormone Receptor Antibodies in Pregnancy: Clinical Relevance.

Authors:  Ines Bucci; Cesidio Giuliani; Giorgio Napolitano
Journal:  Front Endocrinol (Lausanne)       Date:  2017-06-30       Impact factor: 5.555

9.  Epidemiology, management and outcomes of Graves' disease-real life data.

Authors:  Y S Hussain; J C Hookham; A Allahabadia; S P Balasubramanian
Journal:  Endocrine       Date:  2017-05-06       Impact factor: 3.633

10.  The hypothalamic-pituitary-adrenal and -thyroid axes activation lasting one year after an earthquake swarm: results from a big data analysis.

Authors:  G Spaggiari; M Setti; S Tagliavini; L Roli; M C De Santis; T Trenti; V Rochira; D Santi
Journal:  J Endocrinol Invest       Date:  2020-10-29       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.